Background Carnitine orotate complex (Godex) has been shown to decrease glycated hemoglobin levels and improve steatosis in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease. However, the mechanisms of Godex in glucose metabolism remain unclear.
Methods Male C57BL/6J mice were divided into four groups: normal-fat diet, high-fat diet, a high-fat diet supplemented with intraperitoneal injection of (500 mg or 2,000 mg/kg/day) Godex for 8 weeks. Computed tomography, indirect calorimetry, and histological analyses including electron microscopy of the liver were performed, and biochemical profiles and oral glucose tolerance test and insulin tolerance test were undertaken. Expressions of genes in the lipid and glucose metabolism, activities of oxidative phosphorylation enzymes, carnitine acetyltransferase, pyruvate dehydrogenase, and acetyl-coenzyme A (CoA)/CoA ratio were evaluated.
Results Godex improved insulin sensitivity and significantly decreased fasting plasma glucose, homeostatic model assessment for insulin resistance, steatosis, and gluconeogenesis, with a marked increase in fatty acid oxidation as well as better use of glucose in high-fat diet-fed mice. It preserved mitochondrial function and ultrastructure, restored oxidative phosphorylation enzyme activities, decreased acetyl-CoA/CoA ratio, and increased carnitine acetyltransferase content and pyruvate dehydrogenase activity. Carnitine acetyltransferase knockdown partially reversed the effects of Godex in liver and in vitro.
Conclusion Godex improved insulin resistance and steatosis by regulating carnitine acetyltransferase in liver in high-fat diet-fed mice.
Citations
Citations to this article as recorded by
Associations of first-trimester TMAO and its precursors with gestational diabetes mellitus: a pilot prospective cohort study Geng-Dong Chen, Ting-Ting Pang, Peng-Sheng Li, Shao-Xin Ye, Xiao-Yan Gou, Hai-Yan Wang, Dong-Xin Lin, Da-Zhi Fan, Lu-Sha Deng, Li-Juan Wang, Zi-Xing Zhou Frontiers in Nutrition.2025;[Epub] CrossRef
Structural and systems characterization of phosphorylation on metabolic enzymes identifies sex-specific metabolic reprogramming in obesity Tigist Y. Tamir, Shreya Chaudhary, Annie X. Li, Sonia E. Trojan, Cameron T. Flower, Paula Vo, Yufei Cui, Jeffrey C. Davis, Rachit Mukkamala, Francesca N. Venditti, Alissandra L. Hillis, Alex Toker, Matthew G. Vander Heiden, Jessica B. Spinelli, Norman J. Molecular Cell.2025; 85(11): 2211. CrossRef
Dietary hispidulin ameliorated chemically-induced colitis by inhibiting epithelial cell ferroptosis via the ACAT2-GPX4 axis and remodeling the gut microbiota Dapeng Chen, Jiayi Li, Xinyu Li, Kexin Zhang, Shujie Zeng, Shenjun Zhang, Longyun Li, Yongjian Xiong Food & Function.2025; 16(18): 7036. CrossRef
Palmitate-induced hepatic insulin resistance as an in vitro model for natural and synthetic drug screening: A scoping review of therapeutic candidates and mechanisms Bruno Quintanilha Faria, Patricia Sthefani Calixto, Geraldo Picheth, Luana Mota Ferreira, F.G.M. Rego, J.F.C. Guerra, Marcel Henrique Marcondes Sari Chemico-Biological Interactions.2025; 420: 111717. CrossRef
Impact of l-Carnitine Supplementation on Liver Enzyme Normalization in Patients with Chronic Liver Disease: A Meta-Analysis of Randomized Trials Hyunwoo Oh, Chan Hyuk Park, Dae Won Jun Journal of Personalized Medicine.2022; 12(7): 1053. CrossRef
Prolonged Use of Carnitine-Orotate Complex (Godex®) Is Associated with Improved Mortality: A Nationwide Cohort Study Kye-Yeung Park, Sangmo Hong, Kyung-Soo Kim, Kyungdo Han, Cheol-Young Park Journal of Personalized Medicine.2022; 12(12): 1970. CrossRef
The Role of Carnitine Orotate Complex in Fatty Liver Hyon-Seung Yi Diabetes & Metabolism Journal.2021; 45(6): 866. CrossRef